Fig. 27From: The past, present and future of anti-malarial medicinesKey stages in the hit to lead pathway of KAF156. Potential metabolic stability issues were addressed through fluorine bioisosteres giving K2. Introduction of a dimethyl group on the piperazine ring resulted in increased potency and led to the optimized compoundBack to article page